Non-invasive markers of airway inflammation and remodeling in childhood asthma

Pediatric Allergy and Immunology

Volumn 20, Issue 8, 2009, Pages 780-790

  Gagliardo, Rosalia ^a   La Grutta, Stefania ^a,b   Chanez, Pascal ^c,d   Profita, Mirella ^a   Paternò, Alessandra ^e   Cibella, Fabio ^a   Bousquet, Jean ^d   Viegi, Giovanni ^a   Gjomarkaj, Mark ^a  

^a CNR   (Italy)

^b ARPA Sicilia   (Italy)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d INSERM   (France)

^e UNIVERSITY OF PALERMO   (Italy)

Author keywords

Childhood asthma; Exacerbations; Inflammation; Sputum

Indexed keywords

FLUTICASONE PROPIONATE; GELATINASE B; INTERLEUKIN 8; NITRIC OXIDE; SALMETEROL; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR RELA;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; BRONCHITIS; CELL TYPE; CHILD; CHILDHOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG MEGADOSE; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HUMAN; MALE; PATIENT COMPLIANCE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHOOL CHILD; SPUTUM CYTODIAGNOSIS;

ADOLESCENT; ASTHMA; BIOLOGICAL MARKERS; BRONCHITIS; CHILD; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-8; LEUKOCYTE COUNT; MALE; MATRIX METALLOPROTEINASE 9; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 66749178948     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2009.00945.x     Document Type: Article

References (48)

1. Vignola AM, Mirabella F, Costanzo G, et al. Airway remodeling in asthma. Chest 2003 : 123 : 417S 22S.
2. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999 159 (4 Pt 1 1043 1051.
3. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001 : 164 : 2107 2113.
4. Pohunek P, Warner JO, Turzikova J, Kudrmann J, Roche WR. Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol 2005 : 16 : 43 51.
5. Marguet C, Dean TP, Basuyau JP, Warner JO. Eosinophil cationic protein and interleukin-8 levels in bronchial lavage fluid from children with asthma and infantile wheeze. Pediatr Allergy Immunol 2001 : 12 : 27 33.
6. La Grutta S, Gagliardo R, Mirabella F, et al. Clinical and biological heterogeneity in children with moderate asthma. Am J Respir Crit Care Med 2003 : 167 : 1490 1495.
7. Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005 : 171 : 1077 1082.
8. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000 : 106 : 638 644.
9. Wilson NM, James A, Uasuf C, et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 2001 : 12 : 125 132.
10. Sorva R, Metso T, Turpeinen M, Juntunen-Backman K, Björksten F, Haahtela T. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children. Pediatr Allergy Immunol 1997 : 8 : 45 50.
11. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002 : 360 : 1715 1721.
12. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005 : 172 : 831 836.
13. Profita M, Gagliardo R, Di Giorgi R, et al. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics. Allergy 2005 : 60 : 323 329.
14. Vignola AM, Riccobono L, Mirabella A, et al. Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998 : 158 : 1945 1950.
15. Shannon J, Ernst P, Yamauchi Y, et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008 : 133 : 420 426.
16. Gagliardo R, Chanez P, Vignola AM, et al. Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med 2000 : 162 : 7 13.
17. Wilson JW, Li X, Pain MC. The lack of distensibility of asthmatic airways. Am Rev Respir Dis. 1993 : 148 : 806 809.
18. Ohno I, Ohtani H, Nitta Y, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997 : 16 : 212 219.
19. Simpson JL, Scott RJ, Boyle MJ, Gibson PG. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 2005 : 172 : 559 565.
20. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000 : 96 : 2673 2681.
21. Gagliardo R, Chanez P, Mathieu M, et al. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med 2003 : 168 : 1190 1198.
22. Rothwarf DM, Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999 : 1999 : RE1.
23. Gum R, Lengyel E, Juarez J, et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 1996 : 271 : 10672 10680.
24. Wilczynska KM, Gopalan SM, Bugno M, et al. A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes. J Biol Chem 2006 : 281 : 34955 34964.
25. Global Initiative for Asthma (GINA). Workshop report, Global Strategy for Asthma Management and Prevention, 2005 : National Institutes of Health, National Heart, Lung and Blood Institute. NHI Publication N. 02-3659.
26. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005 : 26 : 319 338.
27. Dreborg S. Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen. Allergy 1993 : 48 : 473 475.
28. Eid N, Morton R, Olds B, Clark P, Sheikh S, Looney S. Decreased morning serum cortisol levels in ticasone propionate. Pediatrics 2002 : 109 : 217 221.
29. Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol 1987 : 26 : 221 226.
30. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997 : 337 : 1405 1411.
31. in't Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999 : 160 : 93 9.
32. ATS/ERS. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. American Thoracic Society, European Respiratory Society : 171 : 912 930.
33. Jones PD, Hankin R, Simpson J, Gibson PG, Henry RL. The tolerability, safety, and success of sputum induction and combined hypertonic saline challenge in children. Am J Respir Crit Care Med 2001 : 164 : 1146 1149.
34. Hargreave FE, Popov T, Kidney J, Dolovich J. Sputum measurements to assess airway inflammation in asthma. Allergy. 1993 : 48 : 81 3.
35. Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr 1997 : 131 : 381 385.
36. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993 : 342 : 1510 1513.
37. Kharitonov SA, Gonio F, Kelly C, Meah S, Barnes PJ. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003 : 3 : 433 438.
38. Fritsch M, Uxa S, Horak F Jr., et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006 : 41 : 855 862.
39. Buchvald F, Eiberg H, Bisgaard H. Heterogeneity of FeNO response to inhaled steroid in asthmatic children. Clin Exp Allergy 2003 : 33 : 1735 1740.
40. Robroeks CM, van de Kant KD, Jöbsis Q, et al. Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma. Clin Exp Allergy 2007 : 37 : 1303 1311.
41. Fukakusa M, Bergeron C, Tulic MK, et al. Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa. J Allergy Clin Immunol 2005 : 115 : 280 286.
42. Norzila MZ, Fakes K, Henry RL, Simpson J, Gibson PG. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000 : 161 : 769 774.
43. Cokùraş H, Akçakaya N, Seçkin S, Camciòlu Y, Sarimurat N, Aksoy F. Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax 2001 : 56 : 25 9.
44. Erlewyn-Lajeunesse MD, Hunt LP, Pohunek P, et al. Bronchoalveolar Lavage MMP-9 and TIMP-1 in Preschool Wheezers and Their Relationship to Persistent Wheeze. Pediatr Res 2008 : 64 : 194 199.
45. Lampinen M, Carlson M, Håkansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004 : 59 : 793 805.
46. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005 : 60 : 215 218.
47. Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999 : 160 : 1001 1008.
48. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr., Sorkness CA. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004 : 170 : 426 432.